US Law Firms Embrace Twitter Rival ‘Threads’ Amid High-Profile IP Dispute

In an ever-changing digital landscape, prominent US law firms have begun to explore new avenues for communication and digital presence. These firms are leading the charge in joining ‘Threads’, a rival platform to Twitter. This move comes amidst an unfolding intellectual property (IP) dispute involving two major tech titans, Twitter owner Elon Musk and Meta’s…

Read More

Privileged Email Dismisses Malicious Prosecution Claim in Trademark Battle

In a recent ruling, a Montana federal judge dismissed a malicious prosecution claim lodged against firearm manufacturer, Proof Research Inc. This claim followed a multi-year trademark dispute concerning a rifle barrel with competitor, McGowen Precision Barrels. Key to the dismissal was an inadvertently disclosed email which was deemed protected under attorney-client privilege. This is a…

Read More

USPTO Overrules PTAB Decision, Centripetal Networks Granted Second Chance at Patent Reassessment

In a decisive move from the U.S. Patent and Trademark Office, a decision from the Patent Trial and Appeal Board (PTAB) refusing to reassess a network protection patent belonging to Centripetal Networks has been overruled. The head of the office mandated that the PTAB examine the patent issue anew, offering Centripetal Networks another opportunity to…

Read More

Huawei and ADVA Settle Patent Dispute, Dismiss Lawsuit Amid Licensing Controversy

Huawei and ADVA, two leading telecommunications companies, have mutually agreed to dismiss a contentious lawsuit pending in the Eastern District of Texas. The litigation had alleged that Huawei, a Chinese firm currently under sanctions, was demanding what was perceived as remarkably high royalty rates to license key international telecommunications patents. The lawsuit had even alluded…

Read More

DC Circuit Panel Dismisses FTC Suit Over Opioid Settlement, Supports Exclusive Licensing

In a development that could signal critical implications for pharmaceutical licensing in the United States, a D.C. Circuit panel declined to reinvigorate a lawsuit by the Federal Trade Commission (FTC) that pointed its crosshairs at an opioid medication settlement between Endo Pharmaceuticals and Impax. The dispute originated over the license Endo Pharmaceuticals granted to Impax,…

Read More

Intel and VLSI Technology Pursue Favorable Judgments in Pivotal $900M Chip Patent Dispute

In the impending phase of a multibillion-dollar dispute, tech giant Intel and patent licensing firm VLSI Technology are both seeking a favorable summary judgment from a California federal judge. This particular skirmish revolves around a chip patent case that carries potential implications of up to $900 million. The verdict, anticipated in a trial scheduled for…

Read More

China’s Landmark Ruling in Pharma Antitrust: Balancing Competition and Intellectual Property Rights

The Chinese pharmaceutical sector has oftentimes been a key focus for anti-monopoly investigations. A recent ruling by the Supreme People’s Court in the Yangtze River Pharma v. HIPI Pharma case, is making waves as the first antitrust litigation in China’s active pharmaceutical ingredient sector. According to analysis done by The Brattle Group, the ruling indicates…

Read More

Federal Ruling Highlights Importance of Evidence in Trademark Infringement Cases

A recent federal ruling in Kentucky is commanding the attention of legal professionals and corporations internationally, particularly those involved in issues related to intellectual property and commercial recognition. A Kentucky-based online school that provides continuing education for nurses sought an injunction against a competitor for using its name in advertising. However, the injunction was denied…

Read More

Federal Circuit Ruling Alters Burden of Proof in Trademark Disputes: Implications for Intellectual Property Law

The Federal Circuit has recently issued a decision that could potentially have significant implications for trademark law. The circuit, led by Judge Dyk, has partially challenged a long-standing belief that the burden of proving third-party marks were in use fell on the trademark applicant when determining the strength of the applicant’s mark. In the Spireon…

Read More

Closing the Legal Services Gap: Colorado’s Innovative Approach Inspires Nationwide Reform

Legal services regulation has faced notable changes and challenges, with some believing it is currently experiencing a renaissance–albeit an unevenly paced and fragmented one. A noteworthy move in reshaping this landscape is how Colorado has recently allowed other types of legal providers, apart from attorneys, to offer specific services under certain circumstances. This innovative approach…

Read More

AI-Generated Artwork Ruled Non-Copyrightable, Influencing Intellectual Property and Legal Industries

In a recent advancement within the AI legal landscape, a D.C. federal judge has ruled that AI-generated artwork cannot be copyrighted. The Verge reports that the plaintiff, Stephen Thaler, utilized his own algorithm to create the debated artwork, further blurring the line between artist and AI. Renowned firm ArentFox Schiff recently issued a comprehensive legal…

Read More

Navigating the Biopharma Intellectual Property Maze: Key Insights from KTIPS Seminar

The landscape of intellectual property law, particularly in the biopharma industry, continues to rapidly evolve with technological advancements and legislative reforms. Kilpatrick Townsend recently held its semi-annual KTIPS (Kilpatrick Townsend Intellectual Property Seminar) in San Francisco, where firm attorneys led interactive discussions on these developments. Among the key topics discussed at KTIPS were enablement, written…

Read More